A near 30% increase in Daybue sales above projections, coupled with a lower than expected dropout rate, suggests that the revenue side is undervalued by at least that number, and if half the value of Neuren is made up from the income stream from Daybue, then new analyses should increase the valuation from c$20 to at least $23. Still trading at 50% of its value means it's a buy even with the recent increases.
A near 30% increase in Daybue sales above projections, coupled...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.09 |
Change
-0.220(1.14%) |
Mkt cap ! $2.437B | |||
| Open | High | Low | Value | Volume |
| $19.14 | $19.14 | $18.50 | $7.048M | 371.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 420 | $19.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.09 | 1 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.03 |
Change
-0.220 ( 0.79 %) |
||||
| Open | High | Low | Volume | ||
| $18.96 | $19.10 | $18.52 | 96070 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| NEU (ASX) Chart |